You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 10, October 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS PRESENTED AT THE 63RD ANNUAL MEETING OF THE PACIFIC COAST SURGICAL ASSOCIATION, KAUAI, HAWAII, FEBRUARY 16-19, 1992
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Transhiatal Esophagectomy for Carcinoma of the Esophagus and Cardia

Experience With 160 Cases

Gary A. J. Gelfand, MD; Richard J. Finley, MD; Bill Nelems, MD; Richard Inculet, MD; Kenneth G. Evans, MD; Guy Fradet, MD

Arch Surg. 1992;127(10):1164-1168.


Abstract

• We reviewed our experience from 1979 to 1990 with 160 cases of transhiatal esophagectomy for carcinoma of the lower esophagus and cardia to evaluate trends in patient selection, management, and outcome. Patients treated in the past 6 years (n=110) and those treated before 1985 (n=50) were similar in terms of age and sex distribution, medical history, and weight loss. The majority of tumors seen were adenocarcinoma, with patients in the latter group having significantly lower stages. Significant decreases in anesthetic time, units of blood transfusions, chest tube insertions, length of postoperative ventilation, incidence of postoperative pneumonia, and length of hospital stay were seen during the past 6 years. Wound infections increased significantly during the same period. The decrease in the 30-day mortality rate from 6% to 0.9% was not significant. Survival rates did not differ between groups, with overall rates of 62%, 40%, and 21% at 1, 2, and 5 years, respectively.

(Arch Surg. 1992;127:1164-1168)



Author Affiliations

From the Departments of Surgery, University of British Columbia, Vancouver (Drs Gelfand, Finley, Nelems, Evans, and Fradet), and University of Western Ontario, London (Dr Inculet).


Footnotes

Accepted for publication June 21, 1992.

Presented at the 63rd Annual Meeting of the Pacific Coast Surgical Association, Kauai, Hawaii, February 17, 1992.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Multiple Management Modalities in Esophageal Cancer: Epidemiology, Presentation and Progression, Work-up, and Surgical Approaches
Koshy et al.
The Oncologist 2004;9:137-146.
ABSTRACT | FULL TEXT  

Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy
Doty et al.
Ann. Thorac. Surg. 2002;74:227-231.
ABSTRACT | FULL TEXT  

Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis
Hulscher et al.
Ann. Thorac. Surg. 2001;72:306-313.
ABSTRACT | FULL TEXT  

CATASTROPHIC COMPLICATIONS OF THE CERVICAL ESOPHAGOGASTRIC ANASTOMOSIS
Iannettoni et al.
J. Thorac. Cardiovasc. Surg. 1995;110:1493-1501.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.